Advances in therapy
Transitioning Between Treprostinil Formulations: Evidence and Strategies.
Megan Clarke, Ali Ataya, Alison M Turkin, Raj Parikh, Kyle Davis, Chad E Miller, Alexander Kantorovich, Thomas Winkler, Steven J Cassady
Published: 202510.1007/s12325-025-03401-6
Abstract
Treprostinil is a prostacyclin analog available in four formulations: parenteral, oral, inhalation solution, and inhalation powder. All formulations of treprostinil are indicated for the treatment of pulmonary arterial hypertension; the inhaled formu…
Preview only. Read the full abstract at the source